COMMUNIQUÉS West-GlobeNewswire

Bondholders approve amended terms of the 2025 and 2028 convertible bonds
25/06/2025
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – June 25, 2025 Idorsia Ltd. (SIX: IDIA) today announced the positive outcome of two bondholder meetings held at 17:30 CEST and 19:00 CEST on June 25, [...]
MEME COINS INC., a Controlled Subsidiary of DOGP, to Acquire 2 Billion DOG Tokens from Tipestry
25/06/2025
DOGP Holdings Set to Double to 4.02 Billion DOG MESQUITE, NV, June 25, 2025 (GLOBE NEWSWIRE) -- Denver, CO — MEME COINS INC., a Colorado corporation and controlled subsidiary of Dogecoin Cash Inc. (OTC: DOGP), has [...]
INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent
25/06/2025
SARASOTA, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare company focused on the fertility sector, today announced it has received a notice of [...]
Akari Therapeutics Releases Virtual Investor “What This Means” Segment Highlighting its Recently Granted India Patent
25/06/2025
Access the “What This Means” segment here BOSTON and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody [...]
Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Collaboration with MD Anderson Cancer Center
25/06/2025
Preclinical data demonstrate potent single-agent and combination effects in head and neck squamous cell carcinoma (HNSCC) models, including synergy with anti–PD-1 therapy Initial Phase 1 clinical update shows early [...]
Lifeward Announces Pricing of $2.6 Million Public Oﬀering
25/06/2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of [...]
Dr. Anosh Ahmed Expands National and International COVID Testing Operations with Renewed Emphasis on Compliance and Fraud Prevention
25/06/2025
Dr. Anosh Ahmed expands COVID testing operations globally with renewed focus on compliance, contract integrity, and fraud prevention Chicago, Illinois, June 25, 2025 (GLOBE NEWSWIRE) -- Dr. Anosh Ahmed announces the [...]
Novartis completes acquisition of Regulus Therapeutics
25/06/2025
Basel, June 25, 2025 – Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. (“Regulus”). With the completion of the acquisition, shares of common stock, par value $0. [...]
DBal Max Introduces Legal Dianabol Pills for Muscle Growth: A Safe Steroid Now Available in USA
25/06/2025
London, UK, June 25, 2025 (GLOBE NEWSWIRE) -- In a landmark move set to redefine the muscle-building supplement industry, DBal Max today announced the official launch of its legal Dianabol pills in the USA—a [...]
Gordon Schanzlin New Vision Institute Becomes First U.S. Clinic to Use Alcon’s Breakthrough Unity Phaco System
25/06/2025
Dr. Echegoyen Participated in Clinical Trials for the First Major Phacoemulsification Advancement in Over 15 Years San Diego, CA, June 25, 2025 (GLOBE NEWSWIRE) -- Gordon Schanzlin New Vision Institute is proud to [...]
Safe Legal Steroid Alternatives New Formulation by CrazyBulk: Closest Supplements to Steroids Legally Available In USA
25/06/2025
New York City, June 25, 2025 (GLOBE NEWSWIRE) -- In a significant step forward for the fitness and bodybuilding community, CrazyBulk, a global leader in advanced sports nutrition, is proud to announce the official [...]
Ernst & Young Names USOSM’s Richard Hall an Entrepreneur Of The Year 2025 Southwest Award Winner
25/06/2025
IRVING, Texas, June 25, 2025 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) has announced the winners of its prestigious Entrepreneur Of The Year 2025 Southwest Award, honoring visionary leaders of high-growth [...]
Disclosure of share transfer from Inven2 AS
25/06/2025
Issuer: Zelluna ASA ISIN: NO0013524942 Date of transaction: 25 June 2025 Inven2 AS, a major shareholder in Zelluna ASA, has transferred a total of 120,796 shares in Zelluna ASA to two inventors, in accordance with a pre [...]
OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium
25/06/2025
MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3 rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be [...]
Dr. Anosh Ahmed Announces Major Expansion of COVID Testing Contracts Across U.S. and International Markets
25/06/2025
Dr. Anosh Ahmed expands U.S. and international COVID testing contracts with focus on compliance, fraud prevention, and trusted public health services CHICAGO, June 25, 2025 (GLOBE NEWSWIRE) -- Dr. Anosh Ahmed announces [...]
Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale annuelle et confirme ses perspectives financières 2025
25/06/2025
Saint-Herblain (France), le 25 juin 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que toutes les résolutions recommandées par son conseil d’ [...]
Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance
25/06/2025
Saint-Herblain (France), June 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the [...]
Gold H2 Delivers First Successful Subsurface Bio-Stimulated Hydrogen Production Field Trial
25/06/2025
Breakthrough demonstration in California oilfield validates a new era of clean hydrogen enabled by biotechnology and advanced oilfield services provided by ChampionX LLC HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Gold H [...]
Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer
25/06/2025
Phase 1/2a clinical trial currently supported by a $3.0 million grant from the U.S. Department of Defense Trial will enroll children with high grade glioma and ependymoma HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Plus [...]

Pages